Altimmune (ALT) EBITDA Margin Growth (1y) (2011 - 2025)
Altimmune (ALT) EBITDA Margin Growth (1y) (2011 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Altimmune |
336.67 Mn |
336.67 Mn |
- |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
36.13 Mn |
| Sep 30, 2025 |
7.01 Mn |
| Jun 30, 2025 |
4.98 Mn |
| Mar 31, 2025 |
9.89 Mn |
| Dec 31, 2024 |
-38.10 Mn |
| Sep 30, 2024 |
-44.43 Mn |
| Jun 30, 2024 |
-22.44 Mn |
| Mar 31, 2024 |
-39.60 Mn |
| Dec 31, 2023 |
-217,651.00 |
| Sep 30, 2023 |
117.73 Mn |
| Jun 30, 2023 |
-1.62 Mn |
| Mar 31, 2023 |
-3.43 Mn |
| Dec 31, 2022 |
-8.23 Mn |
| Sep 30, 2022 |
-116.17 Mn |
| Jun 30, 2022 |
-23.47 Mn |
| Mar 31, 2022 |
-5.89 Mn |
| Dec 31, 2021 |
-26,961.00 |
| Sep 30, 2021 |
-2.06 Mn |
| Jun 30, 2021 |
-1.78 Mn |
| Mar 31, 2021 |
-159,608.00 |
